Follow the latest company announcements, clinical research milestones, strategic developments, and updates from Adia Med.
Cell therapy and gene therapy are often used interchangeably, but the FDA treats them as distinct categories. This guide breaks down cell gene therapy through real examples like CAR-T and Casgevy, plus the emerging 2026 hybrid treatments blurring the line between the two.
Regenerative medicine in New Jersey is booming, but not all providers are equally credible. This guide breaks down real costs, insurance coverage, and the regulatory landscape so patients can make informed decisions in 2026.
Standard ‘top companies’ lists rank regenerative medicine companies by revenue or patents, but say nothing about clinical credibility or regulatory compliance. This article offers a three-pillar framework—regulatory status, manufacturing accreditation, and scientific evidence—to help investors, clinicians, and patients separate legitimate providers from risky stem cell clinics.
Typing ‘stem cell hair treatment near me’ into a search bar is easy, but finding a trustworthy provider is harder. This 2026 guide walks you through building a local shortlist, checking FDA and licensing records, and applying an in-clinic vetting framework before you book. Learn what questions to ask so you can separate credible providers from heavily marketed, unregulated offers.
Discover how sickle cell therapy has evolved in 2026, with a side-by-side comparison of conventional treatments, curative gene therapies, and emerging pipeline options. This unbiased guide gives patients, caregivers, and clinicians a practical framework for choosing the right path forward.
Tissue engineering goes far beyond ‘lab-grown skin’ headlines. This 2026 deep dive breaks down scaffolds, cells, and growth factors, examines FDA-approved products like Apligraf and StrataGraft, and explains why vascularization remains the field’s toughest unsolved problem.
A 2025 discovery found hair-forming stem cells may persist in bald scalp, challenging old assumptions about permanent hair loss. This guide breaks down the biology behind stem cell therapy hair growth—from the hair cycle to dermal papilla signaling—and clarifies what’s proven versus promised in 2026.
Stem cell IV therapy promises systemic healing, but the science and regulations behind it are more nuanced than marketing suggests. This 2026 guide breaks down the FDA’s regulatory pathways, the safety risks unique to IV delivery, and what clinical trials like RIMECARD and RESSTORE actually reveal.
Discover a complete range of medical devices examples in 2026, from simple Class I bandages to advanced AI diagnostic software and biologic wound care. This guide breaks down FDA classifications, combination products, and the cutting-edge categories most articles overlook.
Confused by clinic marketing claims about regenerative medicine in NJ? This 2026 guide offers an unbiased look at PRP, BMAC, and exosome therapies, covering FDA regulations, insurance realities, and condition-specific evidence. Use it to evaluate any New Jersey provider before booking a consultation.
In 2026, gene therapy for sickle cell disease reached a new milestone as the FDA expanded approval to children as young as 2. This article breaks down how the leading therapies work, their safety profiles, cost barriers, and the next wave of treatments poised to reshape access worldwide.
Biotechnology isn’t just crops and GMOs—it’s transforming regenerative medicine and wound care right now. This guide breaks down Red biotechnology, exploring cell therapy, tissue engineering, and amniotic biologics in plain language for 2026.
TAKE THE NEXT STEP
Consultations are confidential and conducted by our Orlando-based
clinical staff - for local and international patients alike.
